13

: Prevenar 13. ?  »
|
-

I.M

Suspension For Injection

Active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants, children and adolescents from 6 weeks to 17 years of age.In adults 50 years of age and older, Prevnar 13 is indicated for: active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F. This indication is based on immune responses elicited by Prevnar 13. There have been no controlled trials in adults demonstrating a decrease in invasive pneumococcal disease or pneumococcal pneumonia after vaccination with Prevnar 13.

143 54 33058 00

John Wyeth And Brother Limited; Trading As Wyeth Pharmaceuticals, Uk

06/2010 - X

.
, .
.
/
Pneumococcal polysaccharide serotype 1 2.2 MCG / 0.5 ML
Pneumococcal polysaccharide serotype 14 2.2 MCG / 0.5 ML
Pneumococcal polysaccharide serotype 18c 2.2 MCG / 0.5 ML
Pneumococcal polysaccharide serotype 19 f 2.2 MCG / 0.5 ML
Pneumococcal polysaccharide serotype 19a 2.2 MCG / 0.5 ML
Pneumococcal polysaccharide serotype 23f 2.2 MCG / 0.5 ML
Pneumococcal polysaccharide serotype 3 2.2 MCG / 0.5 ML
Pneumococcal polysaccharide serotype 4 2.2 MCG / 0.5 ML
Pneumococcal polysaccharide serotype 5 2.2 MCG / 0.5 ML
Pneumococcal polysaccharide serotype 6a 2.2 MCG / 0.5 ML
Pneumococcal polysaccharide serotype 6b 4.4 MCG / 0.5 ML
Pneumococcal polysaccharide serotype 7f 2.2 MCG / 0.5 ML
Pneumococcal polysaccharide serotype 9v 2.2 MCG / 0.5 ML
Syringe prefilled glass type i 1 x 0.5 ML 36
Syringe prefilled glass type i 5 x 0.5 ML 36
Syringe prefilled glass type i 10 x 0.5 ML 36
Syringe prefilled glass type i 50 x 0.5 ML 36

*

*

 

.

? !
 »
 
" !
 
301
-